ARCHIVES

Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 8 | August 27, 2010

Download PDF Visit The Full Archive

Related Articles

Fewer Young Scientists win NIH Grants, Study

September 30, 1994

Bush Signs HHS Appropriations; NCI Budget $4.188B After Administrative Rescission.

January 11, 2002

Former DCRRC Chief Saunders Proposes Total Separation Of NCI Intramural, Extramural Research

February 10, 1978

Parkinson Heads Oncology At Amgen

May 2, 2003

DCT Announces Neutron Therapy RFP Available

January 19, 1979

Score Distribution, Other Charts, On P01s

October 2, 1992